Stefan Frings
Stefan Frings is the Deputy Chief Medical Officer at Roche, a leading pharmaceutical company known for its cancer therapies. Recently, he discussed the potential of Roche's new Parkinson's treatment, Prasinezumab, which is entering the final phase of clinical development, highlighting the drug's promise in slowing disease progression amidst the ongoing challenges in the Parkinson's treatment landscape.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Switzerland:
Stefan Frings is the deputy Chief Medical Officer of Roche who provided insights on the Parkinson treatment.
7